A detailed history of Rosenberg Matthew Hamilton transactions in Biogen Inc. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 44 shares of BIIB stock, worth $7,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 44 -0.0%
Holding current value
$7,646
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$190.52 - $236.72 $66,110 - $82,141
-347 Reduced 88.75%
44 $10,000
Q4 2023

Jan 12, 2024

SELL
$222.59 - $267.94 $4,896 - $5,894
-22 Reduced 5.33%
391 $101,000
Q2 2023

Jul 26, 2023

SELL
$275.25 - $318.06 $19,818 - $22,900
-72 Reduced 14.85%
413 $117,000
Q4 2022

Jan 18, 2023

BUY
$252.44 - $306.72 $5,553 - $6,747
22 Added 4.75%
485 $0
Q3 2022

Oct 21, 2022

BUY
$194.69 - $268.46 $1,752 - $2,416
9 Added 1.98%
463 $124,000
Q2 2022

Jul 15, 2022

BUY
$187.54 - $223.02 $64,701 - $76,941
345 Added 316.51%
454 $96,000
Q4 2021

Jan 20, 2022

SELL
$223.92 - $287.77 $5,598 - $7,194
-25 Reduced 18.66%
109 $26,000
Q3 2021

Oct 12, 2021

BUY
$282.99 - $369.05 $7,074 - $9,226
25 Added 22.94%
134 $38,000
Q1 2021

Apr 30, 2021

SELL
$242.95 - $284.63 $6,802 - $7,969
-28 Reduced 20.44%
109 $30,000
Q4 2020

Feb 03, 2021

SELL
$236.26 - $355.63 $10,631 - $16,003
-45 Reduced 24.73%
137 $34,000
Q3 2020

Oct 16, 2020

SELL
$264.77 - $305.71 $21,446 - $24,762
-81 Reduced 30.8%
182 $52,000
Q2 2020

Aug 04, 2020

SELL
$258.66 - $342.55 $25,866 - $34,255
-100 Reduced 27.55%
263 $70,000
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $97,592 - $123,797
363 New
363 $115,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.